Keith Katkin - Jan 10, 2025 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
Director
Signature
/s/ Paul Little, as attorney-in-fact for Keith Katkin
Stock symbol
ELDN
Transactions as of
Jan 10, 2025
Transactions value $
$0
Form type
4
Date filed
1/13/2025, 05:30 PM
Previous filing
May 28, 2024
Next filing
Feb 7, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELDN Stock Option (right to buy) Award $0 +77.2K $0.00 77.2K Jan 10, 2025 Common Stock 77.2K $4.04 Direct F1
transaction ELDN Restricted Stock Units Award $0 +8.58K $0.00 8.58K Jan 10, 2025 Common Stock 8.58K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase up to 77,175 shares of common stock, which option vests with respect to 100% of the total number of shares on January 10, 2026.
F2 Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration.
F3 100% of the restricted stock units will vest on January 10, 2026.